China Shows More Of An Open Door To Overseas Medtech Industry
China's influence on global medtech regulation and the country's continuing emergence on the world stage will be felt increasingly in the coming years. But while China may be less inclined to exclude big medtech multinationals, it feels no compulsion to harmonize totally with the US and/or EU systems.
You may also be interested in...
To the watching world, China dealt quickly and firmly with COVID-19. Seen from within, the health care system is still adapting to the pandemic, but the government is taking the longer view.
US and foreign device manufacturers are being systematically discriminated against in their attempts to sell their medtech products in China, and in working with Chinese regulatory authorities to build successful and beneficial partnerships with China device-makers, says a new report from the US Trade Representative’s office.
Medtech companies' chance to comment on the final draft of amendments to Vietnam's medical device regulations closed in mid-June. The Vietnam Ministry of Health released a translation of the draft to allow multinational companies and other foreign stakeholders full access to the ongoing debate on extending the deadline to the end of 2019, as proposed by industry in the latest exchanges.